Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
This study has been completed.
Sponsor:
University of Wisconsin, Madison
Collaborators:
Sanofi
Bristol-Myers Squibb
ImClone LLC
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00580073
First received: December 17, 2007
Last updated: October 15, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2009 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |